Probiotic lactobacillus reuteri attenuates the stressor-enhanced severity of citrobacter rodentium infection

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3253-3263

  Mackos, Amy R ^a   Eubank, Tim D ^b   Parry, Nicola M A ^c   Bailey, Michael T ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; COLITIS; COLON; COMMUNITY STRUCTURE; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; EXPOSURE; GASTROINTESTINAL INFECTION; GENE EXPRESSION; HISTOPATHOLOGY; HOST SUSCEPTIBILITY; INFECTION SENSITIVITY; INTESTINE FLORA; LACTOBACILLUS REUTERI; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STRESS;

EID: 84884272031     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00278-13     Document Type: Article

References (48)

1. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7:1697-1706.
2. Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67:3031-3039.
3. Lapointe TK, O'Connor PM, Buret AG. 2009. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea. Lab. Invest. 89:964-970.
4. Borenshtein D, McBee ME, Schauer DB. 2008. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 24:32-37.
5. Vallance BA, Deng W, Jacobson K, Finlay BB. 2003. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 71:3443-3453.
6. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, Ma C, Halder S, Montero M, Ionescu VA, Klegeris A, Vallance BA, Gibson DL. 2011. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G39-G49.
7. Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLoS One 6:e26988. doi:10.1371/journal.pone.0026988.
8. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Nunez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325-1329.
9. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79:1536-1545.
10. Chen CC, Louie S, Shi HN, Walker WA. 2005. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr. Res. 58:1185-1191.
11. Johnson-Henry KC, NadjafiM, Avitzur Y, Mitchell DJ, Ngan BY, Galindo-Mata E, Jones NL, Sherman PM. 2005. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J. Infect. Dis. 191:2106-2117.
12. Gareau MG, Wine E, Reardon C, Sherman PM. 2010. Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J. Infect. Dis. 201:81-91.
13. Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. 2012. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J. Infect. Dis. 206:99-109.
14. Buynitsky T, Mostofsky DI. 2009. Restraint stress in biobehavioral research: recent developments. Neurosci. Biobehav. Rev. 33:1089-1098.
15. Bailey MT, Coe CL. 1999. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol. 35:146-155.
16. Bailey MT, Avitsur R, Engler H, Padgett DA, Sheridan JF. 2004. Physical defeat reduces the sensitivity of murine splenocytes to the suppressive effects of corticosterone. Brain Behav. Immun. 18:416-424.
17. Bailey MT, Lubach GR, Coe CL. 2004. Prenatal stress alters bacterial colonization of the gut in infant monkeys. J. Pediatr. Gastroenterol. Nutr. 38:414-421.
18. Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. 2010. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect. Immun. 78:1509-1519.
19. Chen CC, Chiu CH, Lin TY, Shi HN, Walker WA. 2009. Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells. Pediatr. Res. 65:169-175.
20. Foye OT, Huang IF, Chiou CC, Walker WA, Shi HN. 2012. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol. Med. Microbiol. 65:467-480.
21. Brown CH. 1963. Acute emotional crises and ulcerative colitis. Report of seven cases. Am. J. Dig. Dis. 8:525-536.
22. Paar GH, Bezzenberger U, Lorenz-Meyer H. 1988. The correlation of psychosocial stress and disease activity in patients with Crohn disease and ulcerative colitis. Z. Gastroenterol. 26:648-657.
23. Reber SO. 2012. Stress and animal models of inflammatory bowel disease- an update on the role of the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology 37:1-19.
24. Chichlowski M, Hale LP. 2008. Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G1139-G1149.
25. Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J. 2008. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm. Bowel Dis. 14:1068-1083.
26. Jones SE, Versalovic J. 2009. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 9:35. doi:10.1186/1471-2180-9-35.
27. Walter J, Britton RA, Roos S. 2011. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1):4645-4652.
28. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. 2012. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One 7:e31951. doi:10.1371/journal.pone.0031951.
29. Schreiber O, Petersson J, Phillipson M, Perry M, Roos S, Holm L. 2009. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G534-G542.
30. Dicksved J, Schreiber O, Willing B, Petersson J, Rang S, Phillipson M, Holm L, Roos S. 2012. Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One 7:e46399. doi:10.1371/journal.pone.0046399.
31. Head CC, Farrow MJ, Sheridan JF, Padgett DA. 2006. Androstenediol reduces the anti-inflammatory effects of restraint stress during wound healing. Brain Behav. Immun. 20:590-596.
32. Schauer DB, Falkow S. 1993. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect. Immun. 61:4654-4661.
33. Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG. 2003. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162:691-702.
34. Kent S, Bluthe RM, Kelley KW, Dantzer R. 1992. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:24-28.
35. York JM, Blevins NA, Baynard T, Freund GG. 2012. Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors. Methods Mol. Biol. 934:243-276.
36. Belzung C, Griebel G. 2001. Measuring normal and pathological anxietylike behaviour in mice: a review. Behav. Brain Res. 125:141-149.
37. Yin D, Zhang Y, Stuart C, Miao J, Zhang Y, Li C, Zeng X, Hanley G, Moorman J, Yao Z, WoodruffM. 2006. Chronic restraint stress modulates expression of genes in murine spleen. J. Neuroimmunol. 177:11-17.
38. Barthold SW, Osbaldiston GW, Jonas AM. 1977. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab. Anim. Sci. 27:938-945.
39. Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3:333-340.
40. Platt AM, Bain CC, Bordon Y, Sester DP, Mowat AM. 2010. An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation. J. Immunol. 184:6843-6854.
41. Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B, Agace WW, Mowat AM. 2013. Resident and pro-inflammatory macrophages in the colon represent alternative contextdependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6:498-510.
42. Eaton KA, Honkala A, Auchtung TA, Britton RA. 2011. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect. Immun. 79:185-191.
43. O'Neil DA. 2003. Regulation of expression of beta-defensins: endogenous enteric peptide antibiotics. Mol. Immunol. 40:445-450.
44. Vallance BA, Khan MA, Deng W, Gruenheid S, Finlay BB. 2004. Modeling enteropathogenic and enterohemorrhagic E. coli infections and disease. Drug Discov. Today Dis. Models 1:73-79.
45. Muza-Moons MM, Schneeberger EE, Hecht GA. 2004. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells. Cell. Microbiol. 6:783-793.
46. Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, Huang JT, Khan MA, Vallance BA. 2008. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell. Microbiol. 10:388-403.
47. D'Mello C, Swain MG. 2011. Liver-brain inflammation axis. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G749-G761.
48. Collins SM, Barbara G, Vallance B. 1999. Stress, inflammation and the irritable bowel syndrome. Can. J. Gastroenterol. 13(Suppl A):47A-49A.